Authors
Loading...
Randomized trial showed dapagliflozin improves kidney function and vascular stiffness in patients at cardiovascular risk, suggesting potential benefits in management strategies.
Tse et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: